OnKure Therapeutics, Inc.

NasdaqGM:OKUR Stock Report

Market Cap: US$200.4m

OnKure Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of OKUR?
Owner TypeNumber of SharesOwnership Percentage
Institutions1,856,59713.9%
Individual Insiders2,301,21317.2%
VC/PE Firms3,268,26824.4%
Hedge Funds5,963,26544.5%

Dilution of Shares: OKUR only recently listed within the past 12 months

Top Shareholders

Top 25 shareholders own 100.37% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
23%
Highbridge Capital Management, LLC
3,062,690US$46.0m0%1.18%
13.9%
Anthony Piscopio
1,848,409US$27.8m0%no data
13.8%
Cormorant Asset Management, LP
1,837,739US$27.6m0%1.34%
10.8%
Acorn Bioventures
1,439,674US$21.6m0%23.44%
7.97%
Citadel Advisors LLC
1,062,836US$16.0m0%0.02%
7.53%
Perceptive Advisors LLC
1,004,439US$15.1m0%0.34%
6.56%
The Vanguard Group, Inc.
874,654US$13.1m0%no data
6.18%
Samsara BioCapital LLC
824,155US$12.4m0%1.85%
2.59%
BML Capital Management, LLC
345,739US$5.2m0%2.6%
2.02%
Abingworth LLP
269,895US$4.1m0%2.94%
1.69%
Octagon Capital Advisors LP
225,000US$3.4m0%0.56%
0.93%
James Winkler
124,642US$1.9m0%no data
0.88%
James Blake
117,488US$1.8m0%no data
0.77%
Braden Leonard
102,076US$1.5m0%no data
0.54%
BlackRock, Inc.
71,709US$1.1m0%no data
0.49%
Deep Track Capital, LP
66,014US$991.5k0%0.03%
0.47%
Michael Grey
62,884US$944.5k0%no data
0.11%
Nicholas Saccomano
15,062US$226.2k0%no data
0.069%
Edward Mathers
9,150US$137.4k0%no data
0.038%
R. Carruthers
5,124US$77.0k0%no data
0.032%
Isaac Manke
4,250US$63.8k0%no data
0.032%
Andrew Phillips
4,250US$63.8k0%no data
0.032%
Valerie Jansen
4,250US$63.8k0%no data
0.027%
Jason Leverone
3,628US$54.5k0%no data
0.024%
Catalyst Funds Management Pty Ltd
3,200US$48.1k0%0.01%